Literature DB >> 6947275

In vivo effects of antibodies to immune response gene products: prevention of experimental allergic encephalitis.

L Steinman, J T Rosenbaum, S Sriram, H O McDevitt.   

Abstract

Prevention of experimental allergic encephalitis in SJL/J [H-2s] mice was achieved with in vivo administration of antibody reactive with I-As gene products prior to immunization with spinal cord antigen. No protection was evident in animals that received antisera specific for I-Js gene products. Administration of antibody to I-As beginning 5 days after immunization with spinal cord antigen delayed, but did not prevent, the onset of experimental allergic encephalitis.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6947275      PMCID: PMC349205          DOI: 10.1073/pnas.78.11.7111

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  24 in total

1.  Experimental autoimmune encephalomyelitis in mice: genetic control of susceptibility.

Authors:  C C Bernard
Journal:  J Immunogenet       Date:  1976-08

Review 2.  A cardinal role for I-region antigens (Ia) in immunological enhancement, and the clinical implications.

Authors:  D A Davies; N A Staines
Journal:  Transplant Rev       Date:  1976

3.  Regulation of autosensitisation to encephalitogenic myelin basic protein by macrophage-association and soluble antigen.

Authors:  L Steinman; I R Cohen; D Teitelbaum; R Arnon
Journal:  Nature       Date:  1977-01-13       Impact factor: 49.962

4.  Potentiation of a primary in vivo antibody response by alloantisera against gene products of the I region of the H-2 complex.

Authors:  M Pierres; R N Germain; M E Dorf; B Benacerraf
Journal:  Proc Natl Acad Sci U S A       Date:  1977-09       Impact factor: 11.205

5.  Genetic control of antibody production to myelin basic protein in mice.

Authors:  L B Barnett; D E McFarlin
Journal:  J Neuroimmunol       Date:  1981-03       Impact factor: 3.478

6.  Experimental autoimmune encephalomyelitis in mice: immunologic response to mouse spinal cord and myelin basic proteins.

Authors:  C C Bernard; P R Carnegie
Journal:  J Immunol       Date:  1975-05       Impact factor: 5.422

7.  A new I subregion (I-J) marked by a locus (Ia-4) controlling surface determinants on suppressor T lymphocytes.

Authors:  D B Murphy; L A Herzenberg; K Okumura; L A Herzenberg; H O McDevitt
Journal:  J Exp Med       Date:  1976-09-01       Impact factor: 14.307

8.  Selective expression of H-2 (i-region) loci controlling determinants on helper and suppressor T lymphocytes.

Authors:  K Okumura; L A Herzenberg; D B Murphy; H O McDevitt; L A Herzenberg
Journal:  J Exp Med       Date:  1976-09-01       Impact factor: 14.307

9.  Cellular events in the induction of experimental allergic encephalomyelitis in rats.

Authors:  L Ortiz-Ortiz; W O Weigle
Journal:  J Exp Med       Date:  1976-09-01       Impact factor: 14.307

10.  Linkage of susceptibility to experimental allergic encephalomyelitis to the major histocompatibility locus in the rat.

Authors:  R M Williams; M J Moore
Journal:  J Exp Med       Date:  1973-10-01       Impact factor: 14.307

View more
  57 in total

Review 1.  Immunomodulation of autoimmune responses with monoclonal antibodies and immunoadhesins: treatment of ocular inflammatory disease in the next millennium.

Authors:  A D Dick; J D Isaacs
Journal:  Br J Ophthalmol       Date:  1999-11       Impact factor: 4.638

Review 2.  Statin therapy and autoimmune disease: from protein prenylation to immunomodulation.

Authors:  John Greenwood; Lawrence Steinman; Scott S Zamvil
Journal:  Nat Rev Immunol       Date:  2006-05       Impact factor: 53.106

Review 3.  Multiple sclerosis and its animal models: the role of the major histocompatibility complex and the T cell receptor repertoire.

Authors:  L Steinman
Journal:  Springer Semin Immunopathol       Date:  1992

Review 4.  Possibilities for the immunotherapy of rheumatoid arthritis.

Authors:  F C Breedveld; R R De Vries
Journal:  Clin Rheumatol       Date:  1990-06       Impact factor: 2.980

5.  Profile of Lawrence Steinman.

Authors:  Tinsley Davis
Journal:  Proc Natl Acad Sci U S A       Date:  2016-01-25       Impact factor: 11.205

Review 6.  New therapeutic approaches to autoimmune disease.

Authors:  N Talal
Journal:  Springer Semin Immunopathol       Date:  1986

Review 7.  Monoclonal antibodies as magic bullets.

Authors:  F M Brodsky
Journal:  Pharm Res       Date:  1988-01       Impact factor: 4.200

Review 8.  Development of therapies for autoimmune disease at Stanford: a tale of multiple shots and one goal.

Authors:  Lawrence Steinman
Journal:  Immunol Res       Date:  2014-05       Impact factor: 2.829

9.  Production of erythrocyte autoantibodies in NZB mice is inhibited by CD4 antibodies.

Authors:  G G Oliveira; P R Hutchings; I M Roitt; P M Lydyard
Journal:  Clin Exp Immunol       Date:  1994-05       Impact factor: 4.330

10.  Homologies between T cell receptor junctional sequences unique to multiple sclerosis and T cells mediating experimental allergic encephalomyelitis.

Authors:  M Allegretta; R J Albertini; M D Howell; L R Smith; R Martin; H F McFarland; S Sriram; S Brostoff; L Steinman
Journal:  J Clin Invest       Date:  1994-07       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.